Kaplan–Meier and log-rank analyses further established PGC-1α as a crucial prognostic marker, with high expression levels associated with poorer overall survival in patients with glioma, suggesting that it is an independent biomarker for glioma prognosis. This evidence concerns the gene PPARGC1A and central nervous system cancer.